The recent rule from MO HealthNet, Missouri's state Medicaid program, went into effect on the first of January.
Ocugen (OCGN) announced that the first patient has been dosed in the OCU200 Phase 1 clinical trial for diabetic macular edema, DME. “OCU200 has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback